Endogenous Cushing Syndrome
📧 Sign up to get email alerts when something new happens for Endogenous Cushing Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-10-25FDA Approved: MIFEPRISTONE — Supplemental Application (Corcept Therapeutics Incorporated)
The FDA approved a supplemental application for mifepristone from Corcept Therapeutics, updating the drug's labeling/indication.